KRISTINA HALLORAN: Open Payments
NPI 1063062834 · AIEA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,457 in 164 payments from 19 companies in 2025. Trend: 2023 $2,752 · 2024 $2,456 · 2025 $3,457
Food & beverage: $3,348Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $490 |
| GENZYME CORPORATION | 14 | $444 |
| Arcutis Biotherapeutics, Inc. | 20 | $303 |
| UCB, Inc. | 10 | $259 |
| Galderma Laboratories, L.P. | 13 | $237 |
| LEO Pharma Inc. | 16 | $222 |
| Organon LLC | 10 | $216 |
| E.R. Squibb & Sons, L.L.C. | 13 | $212 |
| Genentech USA, Inc. | 14 | $207 |
| Lilly USA, LLC | 7 | $206 |
Products named: DUPIXENT, SKYRIZI, Zoryve, Bimzelx, Sotyktu, Xolair, TALTZ, NEMLUVIO.
Industry payments across HI — which companies pay providers there.
